ACTIV-2d, a global phase 3 trial of novel investigational COVID-19 oral antiviral agent, launches
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which expanded its focus to conduct research into COVID-19, today announced the initiation of ACTIV-2d, a global, phase 3, multicenter trial ...
Aug 22, 2022
0
10